Thermo Fisher Scientific (TMO) PT Raised to $664 at RBC Capital, 'Recovery on Track'
Tweet Send to a Friend
RBC Capital analyst Conor McNamara raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $664.00 (from $660.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
